Efficacy and safety of using vagus nerve stimulation in patients with pharmacoresistant epilepsy in the Russian Federation: a multi-center retrospective observational program

Efficacy and safety of using vagus nerve stimulation in patients with pharmacoresistant epilepsy in the Russian Federation: a multi-center retrospective observational program

Objective: to assess efficacy and safety of vagus nerve stimulation (VNS) in patients with pharmacoresistant epilepsy.Material and methods. A multi-center retrospective observational program was applied in patients with pharmacoresistant epilepsy by using vagus nerve stimulation for at least 2 years...

Full description

Bibliographic Details
Main Authors:	K. V. Voronkova, M. N. Klochkov, N. Yu. Koroleva, S. S. Ivanov, A. B. Dmitriev, E. S. Bolshakova, E. F. Fatykhova, A. A. Usoltseva, D. V. Dmitrenko, A. A. Feygina, Ya. N. Koshelyaevskaya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2021-07-01
Series:	Эпилепсия и пароксизмальные состояния
Subjects:	vagus nerve stimulation, vns-therapy, pharmacoresistant epilepsy, quality of life
Online Access:	https://www.epilepsia.su/jour/article/view/690

Similar Items

EXPERIENCE WITH USE OF CHRONIC NEUROSTIMULATION OF VAGUS NERVE IN TREATMENT OF PHARMACORESISTANT EPILEPSY
by: А. А. Sufianov, et al.
Published: (2016-09-01)

Non-pharmacologic Therapeutic Alternatives for Children with Pharmacoresistant Epilepsy: Vagus Nerve Stimulation and Ketogenic Diet
by: Sibel K Velioğlu
Published: (2014-06-01)

Vagus Nerve Stimulator implantation in a pregnant woman with drug resistant epilepsy
by: M. N. Klochkov, et al.
Published: (2020-01-01)

Vagus Nerve Stimulation as a Gateway to Interoception
by: Albertyna Paciorek, et al.
Published: (2020-07-01)

THE USE OF THE PRINCIPLE OF VESTIBULAR NEUROMODULATION IN COMPLEX TREATMENT OF PHARMACORESISTENT DEPRESSION (clinical observation)
by: A. G. Naryshkin, et al.
Published: (2019-04-01)

Vagus Nerve Stimulation Therapy for Intractable Epilepsy: A Patient’s Perspective
by: Cuthbertson, Mark K.
Published: (2006)

INCIDENCE OF PHARMACORESISTANT EPILEPSY IN KRASNOYARSK REGION (according to neurological center of university hospital data)
by: N. A. Shnayder, et al.
Published: (2016-08-01)

Efficiency of vagus nerve stimulation in epilepsy (literature review and case report)
by: O. A. Pylaeva, et al.
Published: (2019-07-01)

Tragus or cymba conchae? Investigating the anatomical foundation of transcutaneous auricular vagus nerve stimulation (taVNS)
by: Bashar W. Badran, et al.
Published: (2018-07-01)

Vagus nerve stimulation promotes generalization of conditioned fear extinction and reduces anxiety in rats
by: Lindsey J. Noble, et al.
Published: (2019-01-01)

Efficacy and safety of vagal nerve stimulation in patients with pharmacoresistant epilepsy
by: I. G. Areshkina, et al.
Published: (2019-04-01)

Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy
by: Pegah Afra, et al.
Published: (2021-08-01)

A pilot study of the teratogenicity of vagus nerve stimulation in a rabbit model
by: Ingela Danielsson, MD, PhD, et al.
Published: (2009-01-01)

CNS BOLD fMRI Effects of Sham-Controlled Transcutaneous Electrical Nerve Stimulation in the Left Outer Auditory Canal – A Pilot Study
by: Thomas Kraus, et al.
Published: (2013-09-01)

Vagus Nerve Stimulation as a Treatment for Catatonia: A Hypothesis
by: David Zilles
Published: (2019-02-01)

Brain–Heart Interaction During Transcutaneous Auricular Vagus Nerve Stimulation
by: Kathrin Machetanz, et al.
Published: (2021-03-01)

Novel attempts to optimize vagus nerve stimulation parameters on serotonin neuronal firing activity in the rat brain
by: Stella Manta, et al.
Published: (2012-07-01)

Transcutaneous auricular vagus nerve stimulation influences gastric motility: A randomized, double-blind trial in healthy individuals
by: Kenan Steidel, et al.
Published: (2021-09-01)

Editorial: New Frontiers in Noninvasive Brain Stimulation: Cognitive, Affective and Neurobiological Effects of Transcutaneous Vagus Nerve Stimulation
by: Mathias Weymar, et al.
Published: (2021-05-01)

Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects
by: Nishant Verma, et al.
Published: (2021-04-01)

The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature
by: Nicholson WC, et al.
Published: (2017-06-01)

Transcutaneous Vagus Nerve Stimulation (tVNS) and the Dynamics of Visual Bistable Perception
by: Marius Keute, et al.
Published: (2019-03-01)

Efficacy and brain mechanism of transcutaneous auricular vagus nerve stimulation for adolescents with mild to moderate depression: Study protocol for a randomized controlled trial
by: Xue Xiao, et al.
Published: (2020-06-01)

Closed-loop vagus nerve stimulation. Patient-tailored therapy or undirected treatment?
by: Philipp Spindler, et al.
Published: (2021-03-01)

Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
by: Gurpreet Kaur Grewal, et al.
Published: (2017-02-01)

Non-invasive Access to the Vagus Nerve Central Projections via Electrical Stimulation of the External Ear: fMRI Evidence in Humans
by: Eleni Frangos, et al.
Published: (2015-05-01)

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
by: Dell'Osso B, et al.
Published: (2018-03-01)

Feasibility of Non-Invasive Vagus Nerve Stimulation (gammaCore VET™) for the Treatment of Refractory Seizure Activity in Dogs
by: Kelsey Robinson, et al.
Published: (2020-09-01)

Vagus Nerve Stimulation-Induced Laryngeal Motor Evoked Potentials: A Possible Biomarker of Effective Nerve Activation
by: Simone Vespa, et al.
Published: (2019-08-01)

Vagus Nerve Stimulation Therapy Randomized to Different Amounts of Electrical Charge for Treatment-Resistant Depression: Acute and Chronic Effects
by: Scott T. Aaronson, et al.
Published: (2013-07-01)

Short trains of transcutaneous auricular vagus nerve stimulation (taVNS) have parameter-specific effects on heart rate
by: Bashar W. Badran, et al.
Published: (2018-07-01)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
by: Antonella Fattorusso, et al.
Published: (2021-06-01)

Efficacy of Vagus Nerve Stimulation in Patients with Drug Resistant Epilepsy
by: Mecbure Nalbantoğlu, et al.
Published: (2014-03-01)

Super-refractory status epilepticus and pharmacoresistant epilepsy in an infant with hemorrhagic shock and encephalopathy syndrome
by: Kravljanac Ružica, et al.
Published: (2021-01-01)

Vagus nerve stimulation for generalized epilepsy with febrile seizures plus (GEFS+) accompanying seizures with impaired consciousness
by: Ryosuke Hanaya, et al.
Published: (2017-01-01)

The effects of vagus nerve stimulation on the course and outcomes of patients with bipolar disorder in a treatment-resistant depressive episode: a 5-year prospective registry
by: R. Hamish McAllister-Williams, et al.
Published: (2020-05-01)

Reduced Frontal Nogo-N2 With Uncompromised Response Inhibition During Transcutaneous Vagus Nerve Stimulation—More Efficient Cognitive Control?
by: Mia Pihlaja, et al.
Published: (2020-10-01)

A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders
by: Sean L. Thompson, et al.
Published: (2021-07-01)

Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report
by: Adamantios Katerelos, et al.
Published: (2020-02-01)

Experience of Using Vagus Nerve Stimulation to Treat Drug Resistant Epilepsy
by: L. V. Lipatova, et al.
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_fk2qvu1n14il9nofcs04krjj1g